Verrica Pharmaceuticals Announces FDA Acceptance of its IND Application for LTX-315
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that the U.S. Food and Drug Administration has accepted the Company’s Investigational New Drug Application (“IND”) for LTX-315, a potential …
Read More